• mcctly@gmail.com

  • Call Us: 0490 2355881 Fax: 04902355880



National BiopharmaMission is An Industry-Academia Collaborative Mission of the Department of Biotechnology (DBT) for Accelerating Early Development for Biopharmaceuticals; to be implemented by Biotechnology Research Assistance Council (BIRAC).


The Mission Programme is a Pan-India Programme with the main aim of making India a hub for the design and development of novel, affordable and effective biopharmaceutical products and solutions. This Program would aid in enhancing India’s innovation research and product development capabilities, especially by focusing on development of vaccines, biologics and medical devices for combating public health concerns.

Clinical trial is an important step in the product development path requiring multiple trial sites. Indian Biotech companies face numerous challenges in identifying trial sites which have the required infrastructure, capacity, trained manpower, harmonized processes and background data on disease incidence at institutional, local, regional/state, and national levels. The delay in conduct of clinical trials can impact the development timelines of biologics and drugs and thereby delaying the launch of affordable bio similar for Indian population.

To address the above, Department of Biotechnology and National Biopharma Mission’s initiative, formed the clinical trial units within the National Cancer Grid (NCG) to promote multi-centric high-quality clinical trials for affordable therapy in oncology, which will enhance the capability for conduct of Industrysponsored trials of new cancer drugs and biosimilars.

MCC PGIOSR (Post Graduate Institute of Oncology Science & Research) is one of the selected site out of the 11 major cancer centres across India. Tata Memorial Hospital, Mumbai is the Lead site of the multi-centric Clinical Trial Network (CTN) entitled “To establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative research in the field of drug and device development”.

Prospective Registry database in Lymphomas, Chronic MyelogenousLeukemia, Colorectal Cancer, Lung Cancer, and Gall Bladder Cancer is being created across sites of the network.

The Malabar Cancer Center is currently conducting a number of trials, including those supported by pharmaceutical companies and those that are investigator-initiated. We have a committed, highly skilled, and trained clinical trial research team, including a project manager, clinical trial coordinators, research pharmacist, research nurses, and data entry operators, working under the auspices of the CTN network who are trained on Good Clinical Practice (GCP), New Drug Clinical Trial rules 2019 (NDCT-2019), Indian Council of Medical Research (ICMR) guidelines. The institution has 61 academic faculty members who are working under the 15 departments and 40 divisions and have adequate research backgrounds to carry out clinical trials.

Benefits of Collaboration with Clinical Trial Network- BIRAC:

1. Uniform and established SOPs across the network.

2. Access to a larger pool of patients with different geographical regions.

3. Highly qualified and experienced staff.   

4. Easy line of contact. 

5. Calibrated equipment.

List of the hospitals in Clinical Trial Network-BIRAC

S. No.

Hospital Name

Geographic Location

Name of Principal Investigator


Tata Memorial Hospital

Parel, Mumbai

Dr. RajendraBadwe


ACTREC, Kharghar

Navi Mumbai

Dr. JayantSastriGoda


Dr Bhubaneswar Borooah

Cancer Institute

Guwahati, Assam

Dr. Ashok Kumar Das


Homi Bhabha Cancer Hospital

Varanasi, UP

Dr. Satyajit Pradhan


Cancer Institute WIA

Chennai, Tamil Nadu

Dr. SelvaluxmyGanesharajah


Malabar Cancer Centre,

Thalassery, Kerala

Dr. SatheesanBalasubramanian


Max Super Specialty Hospital

Saket, New Delhi

Dr. NiteshRohatgi



Shillong, Meghalaya

Dr. Caleb Harris


Regional Cancer Centre,

Thiruvananthapuram, Kerala

Dr. Beela Sarah Bathew


Christian Medical College,

Vellore, Tamil Nadu

Dr. Vikram Mathews


Cachar Cancer Hospital


Dr. Ravi Kannan

Environmental Health Risk Management Plan (EHRMP)

Click here to download Environmental Health Risk Management Plan (EHRMP)


Address :

Moozhikkara (P.O), Thalassery,
Kannur District, Kerala, India-670103

Phone :

0490 2355881


0490 2355880


This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us:

Subscribe News Letter

Please subscribe electronic version of Abhayam News letter and Nethi- An MCC-Anti-Tobacco cell Publication.
Subscribe now
If any queries please contact E-mail: sm@mcc.kerala.gov.in.

Please publish modules in offcanvas position.